Abnormal expression of MAPK14-related lncRNAs in the peripheral blood of patients with multiple sclerosis
- PMID: 37091283
- PMCID: PMC10114144
- DOI: 10.1016/j.ncrna.2023.03.006
Abnormal expression of MAPK14-related lncRNAs in the peripheral blood of patients with multiple sclerosis
Abstract
Introduction: Contribution of MAPK14 in the pathogenesis of multiple sclerosis (MS) has been proposed by several studies. Long non-coding RNA (lncRNA) have been suggested to be functionally linked with Mitogen-activated protein kinase 14 (MAPK14).
Methods: Expression levels of MAPK14 and its associated lncRNAs were measured in the circulation of MS patients compared with control subjects.
Results: Expression levels of NORAD and RAD51-AS1 were higher in total patients compared with controls (Expression ratio (95% CI) = 1.4 (1.04-1.89), P value = 0.015 and Expression ratio (95% CI) = 1.91 (1.43-2.6), P value = 0.0001, respectively). Conversely, ZNRD1ASP was under-expressed in cases compared with controls (Expression ratio (95% CI) = 0.61 (0.41-0.8), P value = 0.0005). In spite of the observed abnormal expression levels of these lncRNAs in the circulation of MS patients, their expressions were not correlated with Expanded Disability Status Scale (EDSS) score, disease duration or age at disease onset.
Conclusion: To sum up, the current investigation shows dysregulation of MAPK14-related lncRNAs in MS patients.
Keywords: HCG11; Multiple sclerosis; NORAD; RAD51-AS1; ZNRD1ASP; lncRNA.
© 2023 The Authors.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures



Similar articles
-
In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples.Sci Rep. 2020 May 20;10(1):8316. doi: 10.1038/s41598-020-65421-2. Sci Rep. 2020. PMID: 32433496 Free PMC article.
-
Up-regulation of MAPK14-related lncRNAs in the circulation of migraineurs.Sci Rep. 2025 Feb 28;15(1):7250. doi: 10.1038/s41598-025-91943-8. Sci Rep. 2025. PMID: 40021777 Free PMC article.
-
Dysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients.J Mol Neurosci. 2021 Jan;71(1):80-88. doi: 10.1007/s12031-020-01628-2. Epub 2020 Jun 29. J Mol Neurosci. 2021. PMID: 32613554
-
Long non-coding RNAs: From disease code to drug role.Acta Pharm Sin B. 2021 Feb;11(2):340-354. doi: 10.1016/j.apsb.2020.10.001. Epub 2020 Oct 10. Acta Pharm Sin B. 2021. PMID: 33643816 Free PMC article. Review.
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials.Mol Neurobiol. 2025 Aug;62(8):10045-10090. doi: 10.1007/s12035-025-04868-8. Epub 2025 Apr 3. Mol Neurobiol. 2025. PMID: 40180689 Free PMC article. Review.
-
Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways.Int J Mol Sci. 2024 Feb 13;25(4):2255. doi: 10.3390/ijms25042255. Int J Mol Sci. 2024. PMID: 38396932 Free PMC article. Review.
-
Diagnostic efficacy of long non-coding RNAs in multiple sclerosis: a systematic review and meta-analysis.Front Genet. 2024 May 15;15:1400387. doi: 10.3389/fgene.2024.1400387. eCollection 2024. Front Genet. 2024. PMID: 38812967 Free PMC article. Review.
-
Clinical significance of long non-coding RNA NORAD in rheumatoid arthritis.Adv Rheumatol. 2024 Jan 18;64(1):9. doi: 10.1186/s42358-024-00349-z. Adv Rheumatol. 2024. PMID: 38238863
-
Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglected clue in the complex etiopathogenesis of multiple sclerosis.Cell Biosci. 2025 Jun 28;15(1):93. doi: 10.1186/s13578-025-01438-2. Cell Biosci. 2025. PMID: 40581642 Free PMC article.
References
-
- Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7(3):268–277. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous